Study of quality of life and prognostic factors of patients with refractory epilepsy of Essalud’s Miguel Grau Hospital, Lima – Peru

Descripción del Articulo

Introduction: Quality of life is a subjective concept, and there are some questionnaires designed to determine it as accurately as possible, from the patients’ point of view. Objectives: To determine quality of life in patients with refractory epilepsy using the Quality-Of-Life in...

Descripción completa

Detalles Bibliográficos
Autor: Pérez Galdós, Proel
Formato: artículo
Fecha de Publicación:2010
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/1413
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/1413
Nivel de acceso:acceso abierto
Materia:Quality of life
epilepsy
anticonvulsants
Descripción
Sumario:Introduction: Quality of life is a subjective concept, and there are some questionnaires designed to determine it as accurately as possible, from the patients’ point of view. Objectives: To determine quality of life in patients with refractory epilepsy using the Quality-Of-Life in Epilepsy Inventory (QOLIE 31). Material and method: Thirty-five patients from the outpatient neurology clinic were selected in a descriptive and observational study, the QOLIE-31 was administered to them for self-use, and results were compared with socio-demographic and clinical data. Results: 68.6% were male, the mean age: 45.9 years, the average age of onset was: 16.1 years, the average time of disease was: 29.8 years, representing 60 TCG crisis %. An average low quality of life (= 60 points) in the domains: Effects of antiepileptic drugs (AEDs) 44.7, 56.8 cognitive functions and quality of life overall rating 57.1, being the overall score: 58.6 points. Conclusions: Results of the trial show low average values. The items with the lowest scores were follows: effects of antiepileptic drugs and cognitive function disorders, the latter being significantly affected by the use of many different antiepileptic drugs.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).